Quantitative Analysis of the Detergent-Insoluble Brain Proteome in Frontotemporal Lobar Degeneration Using SILAC Internal Standards
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
A hallmark of neurodegeneration is the aggregation of disease related proteins that are resistant to detergent extraction. In the major pathological subtype of frontotemporal lobar degeneration (FTLD), modified TAR-DNA binding protein 43 (TDP-43), including phosphorylated, ubiquitinated, and proteolytically cleaved forms, is enriched in detergent-insoluble fractions from post-mortem brain tissue. Additional proteins that accumulate in the detergent-insoluble FTLD brain proteome remain largely unknown. In this study, we used proteins from stable isotope-labeled (SILAC) human embryonic kidney 293 cells (HEK293) as internal standards for peptide quantitation across control and FTLD insoluble brain proteomes. Proteins were identified and quantified by liquid-chromatography coupled with tandem mass spectrometry (LC-MS/MS) and 21 proteins were determined to be enriched in FTLD using SILAC internal standards. In parallel, label-free quantification of only the unlabeled brain derived peptides by spectral counts (SC) and G-test analysis identified additional brain-specific proteins significantly enriched in disease. Several proteins determined to be enriched in FTLD using SILAC internal standards were not considered significant by G-test due to their low total number of SC. However, immunoblotting of FTLD and control samples confirmed enrichment of these proteins, highlighting the utility of SILAC internal standard to quantify low-abundance proteins in brain. Of these, the RNA binding protein PTB-associated splicing factor (PSF) was further characterized because of structural and functional similarities to TDP-43. Full-length PSF and shorter molecular weight fragments, likely resulting from proteolytic cleavage, were enriched in FTLD cases. Immunohistochemical analysis of PSF revealed predominately nuclear localization in control and FTLD brain tissue and was not associated with phosphorylated pathologic TDP-43 neuronal inclusions. However, in a subset of FTLD cases, PSF was aberrantly localized to the cytoplasm of oligodendrocytes. These data raise the possibility that PSF directed RNA processes in oligodendrocytes are altered in neurodegenerative disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, mass spectrometry has proven to be a valuable tool for locating PTMs implicated in CNS development37 and disorder38, including interrogating specific hypotheses such as the p300-mediated acetylation of Tau39 and the regulation of the transcriptional repressor LSD1 through phosphorylation40.”
From Decoding neuroproteomics: integrating the genome, translatome and functional anatomy (2014) · cites this paper as [38]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Moreover, one study also found no significant effect of frozen storage time on nuclear immunoreactivity for FANS analysis35.”
From Neuron Enriched Nuclear Proteome Isolated from Human Brain (2013) · cites this paper as [35]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“These results are in line with previous reports that brain nuclei are resistant to postmortem degradation or structural changes, in comparison to nuclei of other tissues and cytoplasmic proteins within brain35, 36.”
From Neuron Enriched Nuclear Proteome Isolated from Human Brain (2013) · cites this paper as [35]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In this study, we took advantage of the previously described greater ability of nuclei than cells to survive in post-mortem tissue35, 36 to allow reproducible fractionation and enrichment suitable for proteome analyses.”
From Neuron Enriched Nuclear Proteome Isolated from Human Brain (2013) · cites this paper as [35]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576 · cited 2×
“The most common pathological subtype of frontotemporal lobar degeneration (FTLD) is defined by the presence of TAR DNA binding protein 43 (TDP-43) inclusions [3].”
BackgroundOng, S.-E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A., & Mann, M. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m200025-mcp200 · Cited by 5,574 · cited 1×
“15N) or stable isotope labeling with amino acids in cell culture (SILAC) are being increasingly utilized [9].”
MethodDiagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · cited 1×
“However, with the exception of two rare TARDBP mutations and those individuals harboring mutations in progranulin (PGRN), valosincontaining protein (VCP), or within chromosome 9p [7], the majority of FTLD cases with TDP-43 pathology are idiopathic with no genetic cause identified [4, 5].”
BackgroundProtein aggregation and neurodegenerative disease
Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454 · cited 1×
“The accumulation of detergent-insoluble protein inclusions is observed in a wide variety of neurodegenerative diseases [1, 2].”
BackgroundMutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
Kwiatkowski, T. J., Bosco, D. A., LeClerc, A. L., Tamrazian, E., Vanderburg, C. R., Russ, C., Davis, A., Gilchrist, J., Kasarskis, E. J., Munsat, T., et al. (2009) · Science · doi:10.1126/science.1166066 · Cited by 2,553 · cited 1×
“Based on the structural similarities among PSF, TDP-43, and fused in sarcoma (FUS), another RNA binding protein found in ALS [17] and some FTLD cases [18], we chose to further characterize brain PSF protein in a panel of control and FTLD cases by immunoblotting and immunohistochemistry.”
BackgroundBiology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
Baumann, N., & Pham-Dinh, D. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.871 · Cited by 1,828 · cited 1×
“Oligodendrocytes are a type of glial cell, constituting approximately 50% of all cells around neurons in the frontal cortex and produce myelin in the white matter, which insulates and enhances the speed by which action potentials are propagated on axons [55].”
BackgroundQuantitative mass spectrometry in proteomics: a critical review
Bantscheff, M., Schirle, M., Sweetman, G., Rick, J., & Kuster, B. (2007) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-007-1486-6 · Cited by 1,669 · cited 2×
“Label-free quantification can be performed by peptide spectral counts (SCs) or extracted ion intensity and labeling approaches can include chemical derivitization strategies using isobaric stable isotope tagging reagents, such as tandem mass tags (TMT) or isobaric tags for relative and absolute quantification (iTRAQ)…”
BackgroundMethodPeng, J., Elias, J. E., Thoreen, C. C., Licklider, L. J., & Gygi, S. P. (2003) · Journal of Proteome Research · doi:10.1021/pr025556v · Cited by 1,647 · cited 1×
“To evaluate false discovery rate (FDR), all original protein sequences were reversed to generate a decoy database that was concatenated to the original database (77,764 entries) [29].”
MethodSelf-citation
Research works printed but not linked: 2
- Seyfried NT Huysentruyt LC Atwood JA III Xia Q Seyfried TN Orlando R Up-regulation of NG2 proteoglycan and interferon-induced transmembrane proteins 1 and 3 in mouse astrocytoma: A membrane proteomics approach Cancer Letters 2008 263 243 252 18281150 PMC2726046
- Herskowitz JH Seyfried NT Duong DM Xia Q Rees HD Gearing M Peng J Lah JJ Levey AI Phosphoproteomic Analysis Reveals Site-Specific Changes in GFAP and NDRG2 Phosphorylation in Frontotemporal Lobar Degeneration J Proteome Res PMC2997170 20886841 · DOI · Paper page
Cited by
Stress granules as crucibles of ALS pathogenesis
Li, Y. R., King, O. D., Shorter, J., & Gitler, A. D. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201302044 · Cited by 922
“Moreover, in a subset of FTLD cases, PSF is aberrantly localized to the cytoplasm of oligodendrocytes and forms detergent-insoluble structures (Seyfried et al., 2012).”
BackgroundXu, Z., Poidevin, M., Li, X., Li, Y., Shu, L., Nelson, D. L., Li, H., Hales, C. M., Gearing, M., Wingo, T. S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219643110 · Cited by 340
“human cases were performed following standard procedures (31); further”
MethodSelf-citationA multiregional proteomic survey of the postnatal human brain
Carlyle, B. C., Kitchen, R. R., Kanyo, J. E., Voss, E. Z., Pletikos, M., Sousa, A. M. M., Lam, T. T., Gerstein, M. B., Sestan, N., & Nairn, A. C. (2017) · Nature Neuroscience · doi:10.1038/s41593-017-0011-2 · Cited by 143
Compromised paraspeckle formation as a pathogenic factor in FUSopathies
Shelkovnikova, T. A., Robinson, H. K., Troakes, C., Ninkina, N. N., & Buchman, V. L. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt622 · Cited by 141
“Interestingly, the presence of PSF in the insoluble proteome in FTLD brains has been recently reported (52).”
BackgroundRecent advances in quantitative neuroproteomics
Craft, G. E., Chen, A., & Nairn, A. C. (2013) · Methods · doi:10.1016/j.ymeth.2013.04.008 · Cited by 126
Hales, C. M., Dammer, E. B., Deng, Q., Duong, D. M., Gearing, M., Troncoso, J. C., Thambisetty, M., Lah, J. J., Shulman, J. M., Levey, A. I., et al. (2016) · PROTEOMICS · doi:10.1002/pmic.201600057 · Cited by 99
“Formalin and paraformaldehyde-fixed post-mortem human frontal cortex (50 μm) sections were immunostained essentially as previously described [22].”
MethodSelf-citationSelective Targeting of the Cysteine Proteome by Thioredoxin and Glutathione Redox Systems
Go, Y., Roede, J. R., Walker, D. I., Duong, D. M., Seyfried, N. T., Orr, M. L., Liang, Y., Pennell, K. D., & Jones, D. P. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.030437 · Cited by 105
“Protein quantification was performed using an in-house program that quantified paired light and heavy ICAT peptide peaks (48, 49).”
MethodSelf-citationProteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD
Hedl, T. J., San Gil, R., Cheng, F., Rayner, S. L., Davidson, J. M., De Luca, A., Villalva, M. D., Ecroyd, H., Walker, A. K., & Lee, A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00548 · Cited by 87
Bishof, I., Dammer, E. B., Duong, D. M., Kundinger, S. R., Gearing, M., Lah, J. J., Levey, A. I., & Seyfried, N. T. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001747 · Cited by 80
“Western blotting was performed according to standard procedures as reported previously (5, 10, 68).”
MethodSelf-citationDammer, E. B., Lee, A. K., Duong, D. M., Gearing, M., Lah, J. J., Levey, A. I., & Seyfried, N. T. (2015) · PROTEOMICS · doi:10.1002/pmic.201400189 · Cited by 84
“control and AD phosphopeptides by extracted ion intensity was performed using in-house software as previously described [20-22, 27, 28].”
Self-citationComposition of the Intranuclear Inclusions of Fragile X-associated Tremor/Ataxia Syndrome
Ma, L., Herren, A. W., Espinal, G. M., Randol, J. L., McLaughlin, B. E., Martínez‐Cerdeño, V., Pessah, I. N., Hagerman, R. J., & Hagerman, P. J. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0796-1 · Cited by 79
Neuron Enriched Nuclear Proteome Isolated from Human Brain
Dammer, E. B., Duong, D. M., Diner, I., Gearing, M., Feng, Y., Lah, J. J., Levey, A. I., & Seyfried, N. T. (2013) · Journal of Proteome Research · doi:10.1021/pr400246t · Cited by 70
Self-citationBailey, J., Shen, W., Liang, X., & Crooke, S. T. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx709 · Cited by 74
Decoding neuroproteomics: integrating the genome, translatome and functional anatomy
Kitchen, R. R., Rozowsky, J. S., Gerstein, M. B., & Nairn, A. C. (2014) · Nature Neuroscience · doi:10.1038/nn.3829 · Cited by 63
Aggregation Properties of the Small Nuclear Ribonucleoprotein U1-70K in Alzheimer Disease
Diner, I., Hales, C. M., Bishof, I., Rabenold, L., Duong, D. M., Yi, H., Laur, O., Gearing, M., Troncoso, J., Thambisetty, M., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.562959 · Cited by 63
“Immunohistochemistry—A cryostat was used to cut formalin and paraformaldehyde-fixed post-mortem human frontal cortex into 50- m sections and immuno-stained essentially as described previously (26).”
MethodSelf-citationThe N-degradome of Escherichia coli
Humbard, M. A., Surkov, S., De Donatis, G. M., Jenkins, L. M., & Maurizi, M. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.492108 · Cited by 55
“Statistical analysis was performed using theG test as described previously (31, 32).”
MethodWang, T., Jiang, X., Chen, G., & Xu, J. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.044 · Cited by 58
“…to neurodegenerative diseases (Table 1), including VCP, PSF, Profilin-1, 14-3-3, and ataxin-2elike protein (Elden et al., 2010; Gitcho et al., 2009; Gwinn-Hardy et al., 2000; Johnson et al., 2010; Ke et al., 2012; Malaspina et al., 2000; Pulst et al., 1996; Seyfried et al., 2012; Wu et al., 2012).”
BackgroundInfluentialLauranzano, E., Pozzi, S., Pasetto, L., Stucchi, R., Massignan, T., Paolella, K., Mombrini, M., Nardo, G., Lunetta, C., Corbo, M., et al. (2015) · Brain · doi:10.1093/brain/awv005 · Cited by 53
“spinal cord from mutant SOD1 mice and post-mortem tissues from sporadic ALS and FTLD patients (Basso et al., 2009; Seyfried et al., 2012).”
BackgroundEnrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain
Diner, I., Nguyen, T., & Seyfried, N. T. (2017) · Journal of Visualized Experiments · doi:10.3791/55835 · Cited by 47
“Herein we introduce and discuss an abbreviated single-step detergent-fractionation protocol that is applicable to a wide variety of experimental applications ranging from mass spectrometry-based proteomics analysis to functional protein misfolding assays and western blotting.(5,6,7,10) This methodology is perhaps most…”
BackgroundMethodResultInfluentialSelf-citationIvanova, A., East, M. P., Yi, S. L., & Kahn, R. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.548529 · Cited by 52
“Mass spectrometry, bioinformatics, and quantitation of peptide fold-enrichment were performed as described previously (29, 30).”
MethodHeparin-enriched plasma proteome is significantly altered in Alzheimer’s disease
Guo, Q., Ping, L., Dammer, E. B., Duong, D. M., Yin, L., Xu, K., Shantaraman, A., Fox, E. J., Golde, T. E., Johnson, E. C. B., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00757-1 · Cited by 40
“Western blotting and Coomassie Blue staining were performed on all three fractions from pooled plasma sample (DP input, n = 3; Hp-depleted FT, n = 3; Hp-enriched fraction, n = 3) as previously described [33–35].”
MethodSelf-citationWang, J., Cunningham, R., Zetterberg, H., Asthana, S., Carlsson, C. M., Okonkwo, O. C., & Li, L. (2016) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201600009 · Cited by 38
Pasetto, L., Grassano, M., Pozzi, S., Luotti, S., Sammali, E., Migazzi, A., Basso, M., Spagnolli, G., Biasini, E., Micotti, E., et al. (2021) · Brain · doi:10.1093/brain/awab333 · Cited by 37
“PPIA was found entrapped in aggregates isolated from spinal cord and brain of ALS/FTD patients and mouse models while exerting its protective function against misfolding.(20,48) However, the absence of an overt phenotype in the PPIA–/– mouse in the work of Colgan et al.”
Network Analysis of a Membrane-Enriched Brain Proteome across Stages of Alzheimer’s Disease
Higginbotham, L., Dammer, E., Duong, D., Modeste, E., Montine, T., Lah, J., Levey, A., & Seyfried, N. (2019) · Proteomes · doi:10.3390/proteomes7030030 · Cited by 32
“In preparation for LC-MS/MS analysis, individual membrane (M) fractions (20 μg) from each case including internal standards was reduced with 5 mM dithiothreitol (DTT) for 15 min at 37 ◦C and then alkylated with 20 mM iodoacetamide (IAA) for 30 min at 37 ◦C in the dark [23].”
MethodSelf-citationDiagnostic and prognostic values of PBMC proteins in amyotrophic lateral sclerosis
Luotti, S., Pasetto, L., Porcu, L., Torri, V., Elezgarai, S. R., Pantalone, S., Filareti, M., Corbo, M., Lunetta, C., Mora, G., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104815 · Cited by 35
Pace, M. C., Xu, G., Fromholt, S., Howard, J., Crosby, K., Giasson, B. I., Lewis, J., & Borchelt, D. R. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1895-y · Cited by 31
“Several studies have identified proteins in tissues from AD and tauopathy patients that were insoluble in detergents or otherwise exhibited altered solubility [1, 3, 35, 38, 81, 98] (Online Resource 1, Table S13), and our study identified many of the same proteins (n = 60; Fig.”
Mechanisms of amyloid fibril formation
Dovidchenko, N. V., Леонова, Е. И., & Galzitskaya, O. V. (2014) · Biochemistry (Moscow) · doi:10.1134/s0006297914130057 · Cited by 42
“Moreover, in the case of FTD another RNA binding pro tein, PSF (PTB associated splicing factor), is anomalous ly accumulated in the cytoplasm of oligodendrocytes and forms an insoluble structure [50].”
BackgroundEmerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder
Marchi, F. D., Franjkic, T., Schito, P., Russo, T., Nimac, J., Chami, A. A., Mele, A., Vidatic, L., Križ, J., Julien, J., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061599 · Cited by 31
Kukharsky, M. S., Quintiero, A., Matsumoto, T., Matsukawa, K., An, H., Hashimoto, T., Iwatsubo, T., Buchman, V. L., & Shelkovnikova, T. A. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0014-y · Cited by 33
“Results of several studies suggest a role for paraspeckle proteins and NEAT1 in ALS/FTLD disease pathogenesis [42-49].”
BackgroundCharacterization of Detergent Insoluble Proteome in Chronic Traumatic Encephalopathy
Cherry, J. D., Zeineddin, A., Dammer, E. B., Webster, J. A., Duong, D. M., Seyfried, N. T., Levey, A. I., Alvarez, V. E., Huber, B. R., Stein, T. D., et al. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx100 · Cited by 33
“Given prior success characterizing aggregation prone proteins (4, 6, 29), we sequenced over 4,000 proteins from the CTE detergent insoluble proteome with TMT sample labeling and mass spectrometry.”
MethodSelf-citationGal, J., Chen, J., Katsumata, Y., Fardo, D. W., Wang, W.-X., Artiushin, S., Price, D., Anderson, S., Patel, E., Zhu, H., et al. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx097 · Cited by 28
Guo, Q., Dammer, E. B., Zhou, M., Kundinger, S. R., Gearing, M., Lah, J. J., Levey, A. I., Shulman, J. M., & Seyfried, N. T. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.623659 · Cited by 29
Self-citationSunna, S. N., Bowen, C. A., Zeng, H., Rayaprolu, S., Kumar, P., Bagchi, P., Dammer, E. B., Guo, Q., Duong, D. M., Bitarafan, S., et al. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100546 · Cited by 27
Self-citationTissue-Type Plasminogen Activator Mediates Neuronal Detection and Adaptation to Metabolic Stress
Wu, F., Nicholson, A., Haile, W. B., Torre, E. R., An, J., Chen, C., Lee, A. K., Duong, D. M., Dammer, E. B., Seyfried, N. T., et al. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.124 · Cited by 27
Self-citationHogan, A. L., Grima, N., Fifita, J. A., McCann, E. P., Heng, B., Fat, S. C. M., Wu, S., Maharjan, R. P., Cain, A. K., Henden, L., et al. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12749 · Cited by 27
ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ
Rayner, S. L., Cheng, F., Hogan, A. L., Grima, N., Yang, S., Ke, Y. D., Au, C. G., Morsch, M., Luca, A. D., Davidson, J. M., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab073 · Cited by 26
Karyopherin Alpha 1 Regulates Satellite Cell Proliferation and Survival by Modulating Nuclear Import
Choo, H. J., Cutler, A. A., Rother, F., Bäder, M., & Pavlath, G. K. (2016) · Stem Cells · doi:10.1002/stem.2467 · Cited by 24
“The normalized score and search dependent score for b and y ions were dynamically increased to remove false positive hits [33].”
BackgroundMol, M. O., Miedema, S. S. M., Swieten, J. C. V., van Rooij, J., & Dopper, E. G. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910298 · Cited by 25
Shift of the insoluble content of the proteome in the aging mouse brain
Molzahn, C. M., Kuechler, E. R., Zemlyankina, I., Nierves, L. A., Ali, T., Cole, G., Wang, J., Albu, R. F., Zhu, M., Cashman, N. R., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2310057120 · Cited by 22
“…three centrifugation– MS datasets derived patient tissues including frontotemporal dementia (FTD), Alzheimer’s disease (AD), and chronic traumatic encephalopathy (CTE) cases (Datasets S4 and S5) (45–47), and also one dataset using laser - capture microdissection MS in AD patient tissues (48).”
Proteome of brain glia: The molecular basis of diverse glial phenotypes
Jha, M. K., Kim, J., & Suk, K. (2013) · PROTEOMICS · doi:10.1002/pmic.201300236 · Cited by 20
Gal, J., Katsumata, Y., Zhu, H., Srinivasan, S., Chen, J., Johnson, L. A., Wang, W.-X., Golden, L. R., Wilcock, D. M., Jicha, G. A., et al. (2022) · The American Journal of Pathology · doi:10.1016/j.ajpath.2021.11.013 · Cited by 17
Consequences of impaired purine recycling on the proteome in a cellular model of Lesch–Nyhan disease
Dammer, E. B., Göttle, M., Duong, D. M., Hanfelt, J., Seyfried, N. T., & Jinnah, H. A. (2015) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2015.02.007 · Cited by 18
Self-citationZhang, Y., Kweon, H. K., Shively, C. A., Kumar, A., & Andrews, P. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003077 · Cited by 15
“Because mass spectrometry experiments are time-consuming and costly, most recent studies in proteome research perform two [75,76] or three replicates [77,78] which contributes to the missing data problem in proteomics.”
BackgroundZhou, M., Duong, D. M., Johnson, E. C. B., Dai, J., Lah, J. J., Levey, A. I., & Seyfried, N. T. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00920 · Cited by 15
Self-citationNative low density lipoprotein promotes lipid raft formation in macrophages
Song, J., Ping, L., Duong, D. M., Gao, X., HE, C.-Y., Wei, L., & WU, J.-Z. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4781 · Cited by 15
Self-citationPseudomonas aeruginosa EftM Is a Thermoregulated Methyltransferase
Owings, J. P., Kuiper, E. G., Prezioso, S. M., Meisner, J. S., Varga, J. J., Zelinskaya, N. V., Dammer, E. B., Duong, D. M., Seyfried, N. T., Albertí, S., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.706853 · Cited by 15
“25% for proteins identified by more than one peptide) (23).”
BackgroundSelf-citationAuburger, G. W. J., Gispert, S., & Brehm, N. (2016) · Parkinson s Disease · doi:10.1155/2016/4686185 · Cited by 17
“PSF/SFPQ mislocalized from the neuronal nucleus to the cytoplasm in themotor neuron diseasesALS andFTLD,whichwere caused by TDP-43 mutations [86, 87].”
BackgroundHuff, L. P., Kikuchi, D. S., Faidley, E. A., Forrester, S. J., Tsai, M. Z., Lassegue, B. P., & Griendling, K. K. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00208.2018 · Cited by 13
Kim, D., Bae, G. H., Kim, H. Y., Jeon, H., Kim, K., Shin, J., Lee, S.-H., Hong, S., Kim, I., & Kim, Y. S. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00606 · Cited by 12
Recent Advances in Proteomics Research
Magdeldin, S. (2015) · InTech eBooks · doi:10.5772/59739 · Cited by 10
Kim, D.-W., Lee, J. H., Kim, H. Y., Shin, J., Kim, K., Lee, S., Park, J., Kim, J., & Kim, Y. S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243041 · Cited by 10
“The presence of senile plaques composed of detergent-insoluble Aβ is also observed in AD [24].”
BackgroundLumpkin, C. J., Patel, H., Potts, G. K., Chaurasia, S., Gibilisco, L., Srivastava, G. P., Lee, J. Y., Brown, N. J., Amarante, P., Williams, J. D., et al. (2024) · Molecular Brain · doi:10.1186/s13041-024-01099-1 · Cited by 9
Dominant-negative isoform of TDP-43 is regulated by ALS-linked RNA-binding proteins
Hasegawa-Ogawa, M., 恩田, 亜., Nakajo, T., Funabashi, A., Ohya, A., Yazaki, R., & Okano, H. J. (2025) · The Journal of Cell Biology · doi:10.1083/jcb.202406097 · Cited by 7
Fatemi, S. H., Folsom, T. D., Eschenlauer, A. C., & Chekouo, T. (2025) · The Cerebellum · doi:10.1007/s12311-025-01880-5 · Cited by 7
“Lastly, we identified several proteins considered detergent-insoluble in proteomic studies which lead to protein aggregation and subsequent cellular neurodegenera - tion [ 178–183 ].”
Neuroproteomics — LC-MS Quantitative Approaches
Santa, C., Anjo, S. I., Mendes, V. M., & Manadas, B. J. (2015) · InTech eBooks · doi:10.5772/61298 · Cited by 7
“Within the areas where label-free methods are being used, it is possible to identify some general studies focused on understanding proteomics changes in brain regions, such as the evaluation of frontal cortex changes caused by frontotemporal lobar degeneration (FTLD) [162]; cell- and tumor-specific alterations, such a…”
MethodInfluentialProteomics as an innovative tool to investigate frontotemporal disorders
Agresta, A. M., Palma, A. D., Bardoni, A., Salvini, R., Iadarola, P., & Mauri, P. (2015) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201500090 · Cited by 7
TDP‐43 pathology and functional deficits in wild‐type and ALS/FTD mutant cyclin F mouse models
van Hummel, A., Sabale, M., Przybyla, M., van der Hoven, J., Chan, G., Feiten, A., Chung, R. S., Ittner, L. M., & Ke, Y. D. (2023) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12902 · Cited by 5
“ALS [38] as well as in detergent-insoluble fractions in FTLD cases [39].”
BackgroundBelbin, O., Lehmann, S., Sabidó, E., & Hirtz, C. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00232 · Cited by 5
“They discuss how peptides from stable isotope-labeled (SILAC) human embryonic kidney 293 cells have been used as internal standards to allow quantification of low-abundant proteins across control and FTD brain proteomes (Seyfried et al., 2012) and how Tandem Mass Tagging (TMT) has identified proteome-wide nucleocytopl…”
BackgroundMolzahn, C. M., Nierves, L. A., Lange, P. F., & Mayor, T. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2124-0_3 · Cited by 3
CD45 and Basigin (CD147) Are Functional Ligands for Galectin-8 on Human Leukocytes
Gourdine, J.-P. F., Nava, P., Noll, A. J., Duong, D. M., Seyfried, N. T., & Cummings, R. D. (2025) · Biomolecules · doi:10.3390/biom15091243 · Cited by 2
“In-gel digestion with trypsin and liquid chromatography/tandem mass spectrometry (LC-MS/MS) sequencing were performed as described [28].”
Self-citationLumpkin, C. J., Patel, H., Potts, G. K., Chaurasia, S., Gibilisco, L., Srivastava, G. P., Lee, J. Y., Brown, N. J., Amarante, P., Williams, J. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25885128
Lumpkin, C. J., Patel, H., Potts, G. K., Chaurasia, S., Gibilisco, L., Srivastava, G. P., Lee, J. Y., Brown, N. J., Amarante, P., Williams, J. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25884924
Ma, L., Herren, A. W., Espinal, G. M., Randol, J. L., McLaughlin, B. E., Martinez-Cerdeño, V., Pessah, I. N., Hagerman, R. J., & Hagerman, P. J. (2019) · Figshare · doi:10.6084/m9.figshare.9766562
Developing translational kinetic biomarkers for neurodegenerative disease
Leckey, C. A. (2023) · UCL Discovery (University College London)
Metadata
- Authors
- Seyfried, N. T., Gozal, Y. M., Donovan, L. E., Herskowitz, J. H., Dammer, E. B., Xia, Q., Ku, L., Chang, J., Duong, D. M., Rees, H. D., Cooper, D. S., Glass, J. D., Gearing, M., Tansey, M. G., Lah, J. J., Feng, Y., Levey, A. I., & Peng, J.
- Affiliations
- Emory University (US)
- Corresponding author
- Seyfried, Nicholas T.
- Peng, Junmin
- ORCID
- Venue
- Journal of Proteome Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-04-04
- Volume
- 11
- Issue
- 5
- Pages
- 2721-2738
- ISSN
- 1535-3893 (ISSN-L)
- 1535-3907
- PMC
- PMC3357000
- OpenAlex
- W2040614271
- Cited by
- 64
- References
- 73
- Citations by year
- 2025: 3 · 2024: 3 · 2023: 5 · 2022: 1 · 2021: 6 · 2020: 4 · 2019: 6 · 2018: 2 · 2017: 5 · 2016: 5 · 2015: 7 · 2014: 7 · 2013: 10
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Proteome Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Vanderbilt University
- National Institutes of Health (1f32ag032848-01a1)
- National Institute on Aging (F32 AG032848, F32AG038259, F32AG032848-02, P50AG025688)
- National Institute of General Medical Sciences (T32GM008169)
- National Institute of Neurological Disorders and Stroke (T32NS007480, P30NS055077, F30NS057902)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- frontotemporal lobar degeneration, TDP-43, PSF, oligodendrocytes, neurodegeneration, protein aggregation, proteolytic cleavage, spectral counting, G-test, low-abundance proteins, RNA processing
- MeSH terms
- PTB-Associated Splicing Factor, Aged, Aged, 80 and over, Animals, Brain, Cell Nucleus, Chromatography, Liquid, Cytoplasm, DNA-Binding Proteins, Female, Humans, Isotope Labeling, Male, Middle Aged, Molecular Weight, Neurons, Oligodendroglia, Phosphorylation, RNA-Binding Proteins, Rats, Sprague-Dawley, Proteome, Rats, Tandem Mass Spectrometry, Frontotemporal Lobar Degeneration, HEK293 Cells, Proteolysis, Primary Cell Culture
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.